{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:50:15Z","timestamp":1791532215830,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.canep.2020.101808","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T06:10:17Z","timestamp":1599631817000},"page":"101808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Use of metformin and aspirin is associated with delayed cancer incidence"],"prefix":"10.1016","volume":"69","author":[{"given":"Joseph JY","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason MW","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy SM","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah TY","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin KF","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2020.101808_bib0005","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.canep.2020.101808_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jnci\/djn485","article-title":"Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials","volume":"101","author":"Cole","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"9754","key":"10.1016\/j.canep.2020.101808_bib0015","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"issue":"9826","key":"10.1016\/j.canep.2020.101808_bib0020","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.canep.2020.101808_bib0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijc.32083","article-title":"Long\u2010term use of low\u2010dose aspirin for cancer prevention: A 10\u2010year population cohort study in Hong Kong","volume":"145","author":"Tsoi","year":"2018","journal-title":"Int. J. Cancer."},{"issue":"3","key":"10.1016\/j.canep.2020.101808_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.canep.2020.101808_bib0035","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev. Res. (Phila)"},{"issue":"9","key":"10.1016\/j.canep.2020.101808_bib0040","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.canep.2020.101808_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2407-11-20","article-title":"Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.canep.2020.101808_bib0050","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.canep.2020.101808_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/EDE.0b013e3182093a0f","article-title":"Time-window bias in case-control studies: statins and lung cancer","volume":"22","author":"Suissa","year":"2011","journal-title":"Epidemiology"},{"issue":"10","key":"10.1016\/j.canep.2020.101808_bib0060","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1158\/1055-9965.EPI-13-0196","article-title":"The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus","volume":"22","author":"Smiechowski","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.canep.2020.101808_bib0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-10-0940","article-title":"Metformin and the incidence of prostate cancer in patients with type 2 diabetes","volume":"20","author":"Azoulay","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.canep.2020.101808_bib0070","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.2337\/dc13-1489","article-title":"Incidence of bladder cancer in patients with type 2 diabetes treated with metformin and sulfonylureas","volume":"37","author":"Mamtani","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.canep.2020.101808_bib0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2337\/dc12-0740","article-title":"The use of metformin and the incidence of lung cancer in patients with type 2 diabetes","volume":"36","author":"Smiechowski","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.canep.2020.101808_bib0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.30733","article-title":"Metformin and the incidence of viral associated cancers in patients with type 2 diabetes","volume":"141","author":"Hicks","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"15","key":"10.1016\/j.canep.2020.101808_bib0085","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djt170","article-title":"Association between metformin use and risk of prostate cancer and its grade","volume":"105","author":"Margel","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.canep.2020.101808_bib0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.lungcan.2014.09.012","article-title":"Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner","volume":"86","author":"Tsai","year":"2014","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.canep.2020.101808_bib0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/dmrr.2649","article-title":"Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus","volume":"31","author":"Tseng","year":"2015","journal-title":"Diabetes Metab. Res. Rev"},{"issue":"2","key":"10.1016\/j.canep.2020.101808_bib0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/ije\/dyz005","article-title":"Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models","volume":"48","author":"Farmer","year":"2019","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.canep.2020.101808_bib0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/CEJ.0000000000000442","article-title":"Metformin for lung cancer prevention and improved survival: a novel approach","volume":"28","author":"Roos","year":"2019","journal-title":"Eur. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.canep.2020.101808_bib0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13046-019-1495-2","article-title":"Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects","volume":"38","author":"Kamarudin","year":"2019","journal-title":"J Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canep.2020.101808_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6230162","article-title":"Metformin Use and lung cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"2019","author":"Yao","year":"2019","journal-title":"Dis. Markers"},{"issue":"9596","key":"10.1016\/j.canep.2020.101808_bib0120","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.canep.2020.101808_bib0125","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/biomet\/87.3.706","article-title":"The role of the propensity score in estimating dose-response functions","volume":"87","author":"Imbens","year":"2000","journal-title":"Biometrika"},{"issue":"10","key":"10.1016\/j.canep.2020.101808_bib0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJM195903052601007","article-title":"Diabetes and cancer","volume":"260","author":"Joslin","year":"1959","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.canep.2020.101808_bib0135","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.canep.2020.101808_bib0140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence","volume":"4","author":"El-Serag","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.canep.2020.101808_bib0145","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","article-title":"Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies","volume":"92","author":"Huxley","year":"2005","journal-title":"Br. J. Cancer"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782120301429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782120301429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:15:56Z","timestamp":1791530156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782120301429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"alternative-id":["S1877782120301429"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2020.101808","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of metformin and aspirin is associated with delayed cancer incidence","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2020.101808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101808"}}